Second Echelon Node Study With Methylene Blue

Completed · Not applicable

Conditions studied: Breast Cancer, Melanoma

In brief

The investigators plan to study the ability to identify the lymph nodes beyond the sentinel lymph node that may harbor cancer using methylene blue dye.

Key facts

Study ID

NCT01823172

Run by

Mayo Clinic

People needed

21

Starts

2013-04-01

Expected to finish

2013-11-01

Last updated by the study team

2018-03-23

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Histologically confirmed primary cutaneous melanoma located on the extremity or trunk
• Patients with clinically stage I-II melanoma
• Histologically confirmed invasive ductal or lobular carcinoma
• Patient undergoing surgical treatment of breast primary and sentinel lymph node biopsy- clinically node negative

You may not qualify if…

• Melanoma located on the head or neck, uveal or mucosal
• Previous surgery or radiation in or near the sentinel lymph node biopsy nodal basin
• Preoperative biopsy proven regional lymph node involvement
• Failure of lymphatic mapping with radioactive colloid
• Women who are pregnant or nursing
• Prior ipsilateral axillary surgery or radiation
• Inflammatory breast cancer
• No lymph node identified in the ipsilateral breast during pathologic review of the mastectomy specimen
• Stage IV breast cancer

Where it is running

• Mayo Clinic in Rochester — Rochester, Minnesota, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.